Company press releases
| Tid | Selskap | Tittel | Sektor | Kategori |
|---|---|---|---|---|
| 25 Nov 2025 12:57 CET |
EXACT THERAPEUTICS | EXACT Therapeutics to present company update | 20103010 Biotechnology | Non-regulatory press releases |
| 24 Nov 2025 08:25 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: New option program and receipt of share options by primary insiders | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 25 Sep 2025 08:00 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics first half 2025 interim results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 18 Sep 2025 08:00 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics’ Phase 2 trial to be presented at the 2025 AACR Special Conference | 20103010 Biotechnology | Non-regulatory press releases |
| 09 Sep 2025 08:00 CEST |
EXACT THERAPEUTICS | EXACT Therapeutic’s Acoustic Cluster Therapy to be presented at the Ninth International Cancer lmmunotherapy Conference | 20103010 Biotechnology | Non-regulatory press releases |
| 12 Aug 2025 08:30 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics to Present at the European Society for Medical Oncology (ESMO) Congress 2025 | 20103010 Biotechnology | Non-regulatory press releases |
| 11 Aug 2025 11:08 CEST |
EXACT THERAPEUTICS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Jul 2025 08:30 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics announces grant of core patent in the U.S. | 20103010 Biotechnology | Non-regulatory press releases |
| 24 Jun 2025 08:00 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients with locally advanced pancreatic cancer | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Jun 2025 12:09 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Primary insider notification | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 13 Jun 2025 12:05 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics minutes from Annual General Meeting June 13, 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Jun 2025 09:20 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS – Information regarding voting at the Annual General Meeting 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 May 2025 14:53 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS - Notice of Annual General Meeting 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 May 2025 08:30 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics announces positive final results in Phase 1 ACTIVATE trial in liver metastases from colorectal cancer | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 May 2025 08:35 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics announces grant of key patent covering non-invasive delivery of pharmaceuticals to the brain | 20103010 Biotechnology | Non-regulatory press releases |
| 07 May 2025 10:47 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics announces grant of key patent in Japan | 20103010 Biotechnology | Non-regulatory press releases |
| 09 Apr 2025 21:17 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics - 2024 Annual Report | 20103010 Biotechnology | Annual financial and audit Reports |
| 28 Jan 2025 08:00 CET |
EXACT THERAPEUTICS | EXACT Therapeutics and Cordance Medical Announce Early Encouraging Data in Brain Cancer Mice Model | 20103010 Biotechnology | Non-regulatory press releases |
| 07 Jan 2025 11:58 CET |
EXACT THERAPEUTICS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Dec 2024 12:52 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Share capital increase registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 19 Dec 2024 15:37 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Primary insider notification | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 19 Dec 2024 09:01 CET |
EXACT THERAPEUTICS | EXACT Therapeutics Expands its Board of Directors following the EGM | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Dec 2024 11:36 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Cancellation of subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Dec 2024 12:00 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Minutes from the extraordinary general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Dec 2024 08:00 CET |
EXACT THERAPEUTICS | EXACT Therapeutics Announces FDA Clearance of IND for ENACT, a Phase 2 Trial in Pancreatic Cancer | 20103010 Biotechnology | Non-regulatory press releases |
| 11 Dec 2024 18:47 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Primary insider notification | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 11 Dec 2024 11:44 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Share capital increase registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 03 Dec 2024 14:23 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Notice of extraordinary general meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Dec 2024 08:21 CET |
EXACT THERAPEUTICS | EXACT Therapeutics to host virtual company presentation on December 4, 2024 following the announcement of completion of private placement | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Dec 2024 00:12 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Key information regarding potential subsequent offering | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Dec 2024 00:08 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Private placement successfully placed | 20103010 Biotechnology | Inside information |
| 02 Dec 2024 16:38 CET |
EXACT THERAPEUTICS | EXACT Therapeutics Receives Investment from GE HealthCare to Advance Therapeutic Ultrasound in Pancreatic Cancer using ACT® | 20103010 Biotechnology | Inside information |
| 02 Dec 2024 16:30 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Contemplated Private Placement | 20103010 Biotechnology | Inside information |
| 08 Oct 2024 10:04 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics initiates preclinical immunotherapy collaboration with Agenus Inc. | 20103010 Biotechnology | Non-regulatory press releases |
| 02 Oct 2024 08:30 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics to Present at the bi-annual Contrast Media Research (CMR) Symposium 2024 | 20103010 Biotechnology | Non-regulatory press releases |
| 30 Sep 2024 08:00 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics announces first half 2024 interim results | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 25 Sep 2024 09:00 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics announces grant of immunotherapy patent | 20103010 Biotechnology | Non-regulatory press releases |
| 18 Sep 2024 20:30 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics to Present at the Annual International Symposium on Therapeutic Ultrasound (ISTU 2024) | 20103010 Biotechnology | Non-regulatory press releases |
| 13 Sep 2024 15:18 CEST |
EXACT THERAPEUTICS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Aug 2024 18:33 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics Company update: Full focus on Phase 2 pancreatic cancer trial | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Jun 2024 11:47 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics minutes from Annual General Meeting June 28, 2024 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Jun 2024 09:00 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS - Notice of Annual General Meeting 2024 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 May 2024 09:23 CEST |
EXACT THERAPEUTICS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Apr 2024 20:46 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics Annual report 2023 | 20103010 Biotechnology | Annual financial and audit Reports |
| 10 Apr 2024 08:57 CEST |
EXACT THERAPEUTICS | Additional promising clinical data from EXACT Therapeutics’ ongoing ACTIVATE study presented at AACR Annual Meeting | 20103010 Biotechnology | Non-regulatory press releases |
| 06 Mar 2024 21:05 CET |
EXACT THERAPEUTICS | EXACT Therapeutics to Present at 2024 American Association for Cancer Research (AACR) Annual Meeting | 20103010 Biotechnology | Non-regulatory press releases |
| 22 Jan 2024 14:09 CET |
EXACT THERAPEUTICS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Dec 2023 11:41 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS – Share capital increase registered. Correction. | 20103010 Biotechnology | Total number of voting rights and capital |
| 20 Dec 2023 10:43 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS – Share capital increase registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 14 Dec 2023 09:45 CET |
EXACT THERAPEUTICS | EXACT Therapeutics presenting at DNB Nordic Healthcare conference December 14 | 20103010 Biotechnology | Non-regulatory press releases |